Neurocrine Biosciences director Gary A. Lyons reports sale of $2.47 million in common shares
NBIX•Director Gary A. Lyons sold 15,000 Neurocrine Biosciences common shares on November 17, 2026, at weighted average prices ranging from $163.1106 to $165.8968 per share. He also exercised options for 15,000 shares at $53.64 per share, and reported beneficial ownership of 122,141 shares after the transactions.




